Skip to main content

Carcinoembryonic Antigen (CEA) Market Key Players - F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics

Sellbyville, DE -- (SBWIRE) -- 04/25/2019 -- Carcinoembryonic Antigen Market size is set to reach USD 3.0 billion by 2024; according to a new research study published by Global Market Insights, Inc. Rising geriatric population base coupled with growing number of cancer diseases is driving the carcinoembryonic antigen market size over the forecast timeframe. According to the World Health Organization, cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. Additionally, worldwide, about 1 in 6 deaths is due to cancer. All these factors will propel the global market growth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.